Cargando…

Prognostic biomarker MCP-4 triggers epithelial-mesenchymal transition via the p38 MAPK pathway in ovarian cancer

BACKGROUND: Monocyte chemoattractant protein-4 (MCP-4/CCL13) is a proinflammatory factor that is overexpressed in various malignant tumors and may play an important role in tumor progression and metastasis. However, its role and mechanism of action in ovarian cancer remains unknown. METHODS: Immunoh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Siting, Hu, Yuexin, Liu, Ouxuan, Li, Xiao, Lin, Bei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751588/ https://www.ncbi.nlm.nih.gov/pubmed/36531002 http://dx.doi.org/10.3389/fonc.2022.1034737

Ejemplares similares

RAD21 Confers Poor Prognosis and Affects Ovarian Cancer Sensitivity to Poly(ADP-Ribose)Polymerase Inhibitors Through DNA Damage Repair
por: Gou, Rui, et al.
Publicado: (2022)

Epithelial–Mesenchymal Transition in Ovarian Carcinoma
por: Davidson, Ben, et al.
Publicado: (2012)

PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation
por: Li, Xiao, et al.
Publicado: (2023)

PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes
por: Gou, Rui, et al.
Publicado: (2021)

Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA Sequencing
por: Zheng, Mingjun, et al.
Publicado: (2023)

Keratin 80 regulated by miR-206/ETS1 promotes tumor progression via the MEK/ERK pathway in ovarian cancer
por: Liu, Ouxuan, et al.
Publicado: (2021)

Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
por: Gou, Rui, et al.
Publicado: (2022)

HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathways
por: Nie, Xin, et al.
Publicado: (2022)

YWHAE as an HE4 interacting protein can influence the malignant behaviour of ovarian cancer by regulating the PI3K/AKT and MAPK pathways
por: Li, Xiao, et al.
Publicado: (2021)

Exosomes Regulate the Epithelial–Mesenchymal Transition in Cancer
por: Jiang, Jingwen, et al.
Publicado: (2022)

Chordin-Like 1 Regulates Epithelial-to-Mesenchymal Transition and Metastasis via the MAPK Signaling Pathway in Oral Squamous Cell Carcinoma
por: Wu, Qiuyu, et al.
Publicado: (2022)

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)

SIRT6 Is Involved in the Progression of Ovarian Carcinomas via β-Catenin-Mediated Epithelial to Mesenchymal Transition
por: Bae, Jun Sang, et al.
Publicado: (2018)

Prognostic value of epithelial–mesenchymal transition circulating tumor cells in female breast cancer: A meta-analysis
por: Zhao, Qiang, et al.
Publicado: (2022)

Role of LncRNAs in the Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
por: Ge, Xiaoyong, et al.
Publicado: (2021)

Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor
por: Li, Xiaoxiao, et al.
Publicado: (2022)

Role of Glycans in Cancer Cells Undergoing Epithelial–Mesenchymal Transition
por: Li, Xiang, et al.
Publicado: (2016)

A Gene Prognostic Index Associated With Epithelial-Mesenchymal Transition Predicting Biochemical Recurrence and Tumor Chemoresistance for Prostate Cancer
por: Feng, Dechao, et al.
Publicado: (2022)

GADD45B Promotes Glucose-Induced Renal Tubular Epithelial-Mesenchymal Transition and Apoptosis via the p38 MAPK and JNK Signaling Pathways
por: Xue, Mei, et al.
Publicado: (2020)

The Olfactory Receptor Family 2, Subfamily T, Member 6 (OR2T6) Is Involved in Breast Cancer Progression via Initiating Epithelial-Mesenchymal Transition and MAPK/ERK Pathway
por: Li, Ming, et al.
Publicado: (2019)

Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies
por: Qiao, Lili, et al.
Publicado: (2022)

The Emerging Role of Exosomes in Epithelial–Mesenchymal-Transition in Cancer
por: Vella, Laura Jayne
Publicado: (2014)

LASP2 suppresses colorectal cancer progression through JNK/p38 MAPK pathway meditated epithelial-mesenchymal transition
por: Wang, Bin, et al.
Publicado: (2017)

Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial–Mesenchymal transition
por: Duan, Xirui, et al.
Publicado: (2022)

ncRNAs mediated RPS6KA2 inhibits ovarian cancer proliferation via p38/MAPK signaling pathway
por: Fu, Zhiqin, et al.
Publicado: (2023)

Crosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition
por: Lindsey, Stephan, et al.
Publicado: (2014)

Epithelial to mesenchymal transition in tumor cells as consequence of phenotypic instability
por: García de Herreros, Antonio
Publicado: (2014)

Effects of Epithelial to Mesenchymal Transition on T Cell Targeting of Melanoma Cells
por: Woods, Katherine, et al.
Publicado: (2014)

Epithelial-Mesenchymal Transition and Its Regulation Mechanisms in Pancreatic Cancer
por: Luu, Tuan
Publicado: (2021)

Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer
por: Liu, Yiming, et al.
Publicado: (2021)

Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer
por: Gelissen, Julia H., et al.
Publicado: (2022)

Editorial: Molecular mechanisms of epithelial-mesenchymal transition in cancer metastasis
por: Amin, Amr, et al.
Publicado: (2022)

Advances in the relationship between ferroptosis and epithelial–mesenchymal transition in cancer
por: Mu, Wenrong, et al.
Publicado: (2023)

The Role of the p38 MAPK Signaling Pathway in High Glucose-Induced Epithelial-Mesenchymal Transition of Cultured Human Renal Tubular Epithelial Cells
por: Lv, Zhi-Mei, et al.
Publicado: (2011)

A prognostic system for epithelial ovarian carcinomas using machine learning
por: Grimley, Philip M., et al.
Publicado: (2021)

CCNDBP1, a Prognostic Marker Regulated by DNA Methylation, Inhibits Aggressive Behavior in Dedifferentiated Liposarcoma via Repressing Epithelial Mesenchymal Transition
por: Yang, Lingge, et al.
Publicado: (2021)

Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition?
por: da Fonseca, Leonardo Marques, et al.
Publicado: (2016)

Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors
por: Morandi, Andrea, et al.
Publicado: (2017)

Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer
por: Zhong, Weilong, et al.
Publicado: (2023)

Novel Potential Biomarkers Associated With Epithelial to Mesenchymal Transition and Bladder Cancer Prognosis Identified by Integrated Bioinformatic Analysis
por: Wang, Chengyuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uac5aihdu6rntvgbv9c9caeu35